A Method for Intratumoral Continuous Infusion of Antisense Oligodeoxynucleotides
- 1 March 1998
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 87 (3) , 387-389
- https://doi.org/10.1021/js970339s
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Monthly Updates: Monthly Update Biologicals & Immunologicals: Progress in the development of antisense drugsExpert Opinion on Investigational Drugs, 1996
- Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expressionBritish Journal of Cancer, 1996
- Antisense phosphorothioate oligodeoxynucleotides: introductory concepts and possible molecular mechanisms of toxicityToxicology Letters, 1995
- Ability of Oligonucleotides with Certain Palindromes to Induce Interferon Production and Augment Natural Killer Cell Activity Is Associated with Their Base LengthAntisense Research and Development, 1994
- Over-expression of the c-myc proto-oncogene in colorectal carcinomaBritish Journal of Cancer, 1993
- Relationship of c-myc Amplification to Progression of Breast Cancer From In Situ to Invasive Tumor and Lymph Node MetastasisJNCI Journal of the National Cancer Institute, 1993
- C-myc oncogene expression in anal squamous neoplasia.Journal of Clinical Pathology, 1993
- Control of c-myc Regulation in Normal and Neoplastic CellsPublished by Elsevier ,1991